Recombinant R-spondin2 and Wnt3a up- and down-regulate novel target genes in C57MG mouse mammary epithelial cells

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Baljinnyam, Bolormaa ^a   Klauzinska, Malgorzata ^a   Saffo, Saad ^a   Callahan, Robert ^a   Rubin, Jeffrey S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; GLYCOPROTEIN; GROWTH FACTOR; R SPONDIN2 PROTEIN; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT3A PROTEIN; BETA CATENIN; RSPO2 PROTEIN, MOUSE; THROMBOSPONDIN; WNT3A PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL FATE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; GENE TARGETING; IMMUNE RESPONSE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ORGANOGENESIS; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; EVALUATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; UDDER; VALIDATION STUDY;

ANIMALS; BETA CATENIN; CELL LINE; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MAMMARY GLANDS, ANIMAL; MICE; MICROARRAY ANALYSIS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; THROMBOSPONDINS; UP-REGULATION; VALIDATION STUDIES AS TOPIC; WNT3A PROTEIN;

EID: 84855416391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029455     Document Type: Article

References (77)

1. Chen JZ, Wang S, Tang R, Yang QS, Zhao E, et al. (2002) Cloning and identification of a cDNA that encodes a novel human protein with thrombospondin type I repeat domain, hPWTSR. Mol Biol Rep 29: 287-292.
2. Kamata T, Katsube K, Michikawa M, Yamada M, Takada S, et al. (2004) R-spondin, a novel gene with thrombospondin type 1 domain, was expressed in the dorsal neural tube and affected in Wnts mutants. Biochim Biophys Acta 1676: 51-62.
3. Nam JS, Turcotte TJ, Yoon JK, (2007) Dynamic expression of R-spondin family genes in mouse development. Gene Expr Patterns 7: 306-312.
4. Kazanskaya O, Glinka A, del Barco Barrantes I, Stannek P, Niehrs C, et al. (2004) R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. Dev Cell 7: 525-534.
5. Kim KA, Zhao J, Andarmani S, Kakitani M, Oshima T, et al. (2006) R-Spondin proteins: a novel link to beta-catenin activation. Cell Cycle 5: 23-26.
6. Nam JS, Park E, Turcotte TJ, Palencia S, Zhan X, et al. (2007) Mouse R-spondin2 is required for apical ectodermal ridge maintenance in the hindlimb. Dev Biol 311: 124-135.
7. Aoki M, Kiyonari H, Nakamura H, Okamoto H, (2008) R-spondin2 expression in the apical ectodermal ridge is essential for outgrowth and patterning in mouse limb development. Dev Growth Differ 50: 85-95.
8. Bell SM, Schreiner CM, Wert SE, Mucenski ML, Scott WJ, et al. (2008) R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. Development 135: 1049-1058.
9. Friedman MS, Oyserman SM, Hankenson KD, (2009) Wnt11 promotes osteoblast maturation and mineralization through R-spondin 2. J Biol Chem 284: 14117-14125.
10. Aoki M, Mieda M, Ikeda T, Hamada Y, Nakamura H, et al. (2007) R-spondin3 is required for mouse placental development. Dev Biol 301: 218-226.
11. Kazanskaya O, Ohkawara B, Heroult M, Wu W, Maltry N, et al. (2008) The Wnt signaling regulator R-spondin 3 promotes angioblast and vascular development. Development 135: 3655-3664.
12. Parma P, Radi O, Vidal V, Chaboissier MC, Dellambra E, et al. (2006) R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat Genet 38: 1304-1309.
13. Blaydon DC, Ishii Y, O'Toole EA, Unsworth HC, Teh MT, et al. (2006) The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia. Nat Genet 38: 1245-1247.
14. Bergmann C, Senderek J, Anhuf D, Thiel CT, Ekici AB, et al. (2006) Mutations in the gene encoding the Wnt-signaling component R-spondin 4 (RSPO4) cause autosomal recessive anonychia. Am J Hum Genet 79: 1105-1109.
15. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
16. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
17. Klaus A, Birchmeier W, (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8: 387-398.
18. Kim KA, Kakitani M, Zhao J, Oshima T, Tang T, et al. (2005) Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 309: 1256-1259.
19. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, et al. (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459: 262-265.
20. Cadigan KM, (2008) Wnt/beta-catenin signaling: turning the switch. Dev Cell 14: 322-323.
21. MacDonald BT, Tamai K, He X, (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
22. Nam JS, Turcotte TJ, Smith PF, Choi S, Yoon JK, (2006) Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression. J Biol Chem 281: 13247-13257.
23. Wei Q, Yokota C, Semenov MV, Doble B, Woodgett J, et al. (2007) R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling. J Biol Chem 282: 15903-15911.
24. Binnerts ME, Kim KA, Bright JM, Patel SM, Tran K, et al. (2007) R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proc Natl Acad Sci U S A 104: 14700-14705.
25. Kim KA, Wagle M, Tran K, Zhan X, Dixon MA, et al. (2008) R-Spondin family members regulate the Wnt pathway by a common mechanism. Mol Biol Cell 19: 2588-2596.
26. Ellwanger K, Saito H, Clement-Lacroix P, Maltry N, Niedermeyer J, et al. (2008) Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density. Mol Cell Biol 28: 4875-4882.
27. Semenov MV, Zhang X, He X, (2008) DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. J Biol Chem 283: 21427-21432.
28. Li SJ, Yen TY, Endo Y, Klauzinska M, Baljinnyam B, et al. (2009) Loss-of-function point mutations and two-furin domain derivatives provide insights about R-spondin2 structure and function. Cell Signal 21: 916-925.
29. Glinka A, Dolde C, Kirsch N, Huang YL, Kazanskaya O, et al. (2011) LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling. EMBO Rep 12: 1055-1061.
30. Carmon KS, Gong X, Lin Q, Thomas A, Liu Q, (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/{beta}-catenin signaling. Proc Natl Acad Sci U S A 108: 11452-11457.
31. de Lau W, Barker N, Low TY, Koo BK, Li VS, et al. (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476: 293-297.
32. Nusse R, Varmus HE, (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99-109.
33. Nusse R, van Ooyen A, Cox D, Fung YK, Varmus H, (1984) Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307: 131-136.
34. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE, (1988) Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619-625.
35. Lowther W, Wiley K, Smith GH, Callahan R, (2005) A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences. J Virol 79: 10093-10096.
36. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, et al. (2007) MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 39: 759-769.
37. Klauzinska M, Baljinnyam B, Raafat A, Rodriguez-Canales J, Strizzi L, et al. (2011) Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells. J Cell Physiol In press.
38. Kikuchi A, Yamamoto H, (2008) Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci 99: 202-208.
39. Sugimura R, Li L, (2010) Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res C Embryo Today 90: 243-256.
40. Ohkawara B, Glinka A, Niehrs C, (2011) Rspo3 binds syndecan 4 and induces Wnt/PCP signaling via clathrin-mediated endocytosis to promote morphogenesis. Dev Cell 20: 303-314.
41. Howe LR, Subbaramaiah K, Chung WJ, Dannenberg AJ, Brown AM, (1999) Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res 59: 1572-1577.
42. Szeto W, Jiang W, Tice DA, Rubinfeld B, Hollingshead PG, et al. (2001) Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. Cancer Res 61: 4197-4205.
43. Tao W, Pennica D, Xu L, Kalejta RF, Levine AJ, (2001) Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev 15: 1796-1807.
44. Prieve MG, Moon RT, (2003) Stromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57mg mouse mammary epithelial cells. BMC Dev Biol 3: 2.
45. Taneyhill L, Pennica D, (2004) Identification of Wnt responsive genes using a murine mammary epithelial cell line model system. BMC Dev Biol 4: 6.
46. Ziemer LT, Pennica D, Levine AJ, (2001) Identification of a mouse homolog of the human BTEB2 transcription factor as a beta-catenin-independent Wnt-1-responsive gene. Mol Cell Biol 21: 562-574.
47. Niehrs C, (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25: 7469-7481.
48. Staal FJ, Luis TC, Tiemessen MM, (2008) WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol 8: 581-593.
49. van de Wetering M, de Lau W, Clevers H, (2002) WNT signaling and lymphocyte development. Cell 109 Suppl pp. S13-19.
50. Liu H, Fergusson MM, Wu JJ, Rovira II, Liu J, et al. (2011) Wnt signaling regulates hepatic metabolism. Sci Signal 4: ra6.
51. Tice DA, Szeto W, Soloviev I, Rubinfeld B, Fong SE, et al. (2002) Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling. J Biol Chem 277: 14329-14335.
52. Wang J, Lu Y, Wang J, Koch AE, Zhang J, et al. (2008) CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. Cancer Res 68: 10367-10376.
53. Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, et al. (2008) The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. Cancer Res 68: 4701-4708.
54. Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YY, Maeda S, et al. (2009) The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PLoS One 4: e6695.
55. Lin S, Sun L, Hu J, Wan S, Zhao R, et al. (2009) Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia. Cancer Lett 279: 108-117.
56. Kaidi A, Williams AC, Paraskeva C, (2007) Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9: 210-217.
57. Kurowska-Stolarska M, Hueber A, Stolarski B, McInnes IB, (2010) Interleukin-33: a novel mediator with a role in distinct disease pathologies. J Intern Med 269: 29-35.
58. Molenaar AJ, Harris DP, Rajan GH, Pearson ML, Callaghan MR, et al. (2009) The acute-phase protein serum amyloid A3 is expressed in the bovine mammary gland and plays a role in host defence. Biomarkers 14: 26-37.
59. Bommer GT, Feng Y, Iura A, Giordano TJ, Kuick R, et al. (2010) IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype. J Biol Chem 285: 1928-1938.
60. Peyrat JP, Bonneterre J, Vennin PH, Jammes H, Beuscart R, et al. (1990) Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors. J Steroid Biochem Mol Biol 37: 823-827.
61. Attisano L, Labbe E, (2004) TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev 23: 53-61.
62. Dailey L, Ambrosetti D, Mansukhani A, Basilico C, (2005) Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16: 233-247.
63. Chesire DR, Dunn TA, Ewing CM, Luo J, Isaacs WB, (2004) Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells. Cancer Res 64: 2523-2533.
64. Beischlag TV, Luis Morales J, Hollingshead BD, Perdew GH, (2008) The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 18: 207-250.
65. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, et al. (2007) Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446: 562-566.
66. Ohtake F, Fujii-Kuriyama Y, Kato S, (2009) AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochem Pharmacol 77: 474-484.
67. Zhang S, Lei P, Liu X, Li X, Walker K, et al. (2009) The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy. Endocr Relat Cancer 16: 835-844.
68. Hall JM, Barhoover MA, Kazmin D, McDonnell DP, Greenlee WF, et al. (2010) Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Mol Endocrinol 24: 359-369.
69. Kawajiri K, Kobayashi Y, Ohtake F, Ikuta T, Matsushima Y, et al. (2009) Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands. Proc Natl Acad Sci U S A 106: 13481-13486.
70. Mathew LK, Sengupta SS, Ladu J, Andreasen EA, Tanguay RL, (2008) Crosstalk between AHR and Wnt signaling through R-Spondin1 impairs tissue regeneration in zebrafish. Faseb J 22: 3087-3096.
71. Prochazkova J, Kabatkova M, Bryja V, Umannova L, Bernatik O, et al. (2011) The interplay of the aryl hydrocarbon receptor and beta-catenin alters both AhR-dependent transcription and Wnt/beta-catenin signaling in liver progenitors. Toxicol Sci 122: 349-360.
72. Braeuning A, Kohle C, Buchmann A, Schwarz M, (2011) Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway. Toxicol Sci 122: 16-25.
73. Dong JT, Chen C, (2009) Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci 66: 2691-2706.
74. Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, et al. (2006) The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell 21: 799-809.
75. Xu Q, Akama R, Isaji T, Lu Y, Hashimoto H, et al. (2011) Wnt/beta-catenin signaling down-regulates N-acetylglucosaminyltransferase III expression: the implications of two mutually exclusive pathways for regulation. J Biol Chem 286: 4310-4318.
76. Zhu LJ, Altmann SW, (2005) mRNA and 18S-RNA coapplication-reverse transcription for quantitative gene expression analysis. Anal Biochem 345: 102-109.
77. Endo Y, Beauchamp E, Woods D, Taylor WG, Toretsky JA, et al. (2008) Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism. Mol Cell Biol 28: 2368-2379.